Federated Hermes’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.26M | Sell |
534,027
-7,892
| -1% | -$122K | 0.02% | 615 |
|
|
2025
Q1 | $8.06M | Buy |
541,919
+106,885
| +25% | +$1.59M | 0.02% | 605 |
|
|
2024
Q4 | $5.76M | Sell |
435,034
-107,719
| -20% | -$1.43M | 0.01% | 671 |
|
|
2024
Q3 | $7.72M | Buy |
542,753
+161,880
| +43% | +$2.3M | 0.02% | 623 |
|
|
2024
Q2 | $4.93M | Sell |
380,873
-209,700
| -36% | -$2.71M | 0.01% | 718 |
|
|
2024
Q1 | $8.2M | Buy |
590,573
+152,249
| +35% | +$2.11M | 0.02% | 607 |
|
|
2023
Q4 | $6.25M | Sell |
438,324
-125,449
| -22% | -$1.79M | 0.02% | 668 |
|
|
2023
Q3 | $8.72M | Sell |
563,773
-18,089
| -3% | -$280K | 0.02% | 566 |
|
|
2023
Q2 | $9.14M | Sell |
581,862
-19,767
| -3% | -$311K | 0.02% | 562 |
|
|
2023
Q1 | $9.91M | Buy |
601,629
+310,512
| +107% | +$5.12M | 0.02% | 547 |
|
|
2022
Q4 | $4.54M | Buy |
+291,117
| New | +$4.54M | 0.01% | 701 |
|